The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1353-1359

  Chang, Haiping ^a   Wang, Jingzhi ^a   Tian, Yuan ^a   Xu, Jie ^a   Gou, Xiaojuan ^a   Cheng, Jianxin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Diagnosis; siRNA; Targeting protein for Xenopus kinesin like protein 2; Treatment

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; SMALL INTERFERING RNA; TARGETING PROTEIN FOR XENOPUS KINESIN LIKE PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TPX2 GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE SILENCING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS;

EID: 84863294054     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1668     Document Type: Article

References (18)

1. Kufer TA, Sillje HH, Korner R, Gruss OJ, Meraldi P and Nigg EA: Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 158: 617-623, 2002. (Pubitemid 34920101)
2. Zhang L, He H, Deng L, Chu M, Xu L, Fu J, et al: TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7, 8-diol-9, 10-epoxide. Toxicology 252: 49-55, 2008.
3. Shigeishi H, Ohta K, Hiraoka M, Fujimoto S, Minami M, Higashikawa K and Kamata N: Expression of TPX2 in salivary gland carcinomas. Oncol Rep 21: 341-344, 2009.
4. Ma Y, Lin D, Sun W, Xiao T, Yuan J and Han N: Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin Cancer Res 12: 1121-1127, 2006. (Pubitemid 43342499)
5. Mohsenifar J, Almassi-Aghdam M, Mohammad-Taheri Z, Zare K, Jafari B, Atri M, et al: Prognostic values of proliferative markers ki-67 and repp86 in breast cancer. Arch Iran Med 10: 27-31, 2007. (Pubitemid 46188961)
6. Gruss OJ and Vernos I: The mechanism of spindle assembly: functions of Ran and its target TPX2. J Cell Biol 166: 949-955, 2004. (Pubitemid 39304757)
7. Gruss OJ, Carazo-Salas RE, Schatz CA, Guarguaglini G, Kast J and Wilm M: Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity. Cell 104: 83-93, 2001. (Pubitemid 32144974)
8. Bayliss R, Sardon T, Ebert J, Lindner D, Vernos I and Conti E: Determinants for Aurora-A activation and Aurora-B discrimination by TPX2. Cell Cycle 3: 404-407, 2004. (Pubitemid 40278221)
9. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, et a1: High-resolution genomic profiles of human lung cancer.Proc Natl Acad Sci USA 102: 9625-9630, 2005.
10. Scharer CD, Laycock N, Osunkoya AO, Logani S, McDonald JF, Benigno BB, et al: Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. Transl Med 6: 79, 2008.
11. Warner SL, Stephens BJ, Nwokenkwo S, Hostetter G, Sugeng A, Hidalgo M, et al: Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res 15: 6519-6528, 2009.
12. Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A, et al: Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol 70: 1-12, 2011.
13. Li B, Qi XQ, Chen X, Huang X, Liu GY, Chen HR, et al: Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma. Brain Res 1352: 200-207, 2010.
14. Brizova H, Kalinova M, Krskova L, Mrhalova M and Kodet R: A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIalpha and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma. Virchows Arch 456: 671-679, 2010.
15. Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami H, et al: Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 16: 2518-2528, 2010.
16. Shigeishi H, Fujimoto S, Hiraoka M, Ono S, Taki M, Ohta K, et al: Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol 34: 1565-1571, 2009.
17. Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, Long S, et al: 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome. Genes Chromosomes Cancer 45: 957-966, 2006. (Pubitemid 44360183)
18. Bian M, Fu J, Yan Y, Chen Q, Yang C, Shi Q, et al: Short exposure to paclitaxel induces multipolar spindle formation and aneuploidy through promotion of acentrosomal pole assembly.Sci China Life Sci 53: 1322-1329, 2010.